|
|
|
|
| LEADER |
00833cas#a2200289#a#4500 |
| 001 |
018386 |
| 005 |
20250328123208.0 |
| 008 |
061109d19651996sp#qu#p#######0####|spa#d |
| 999 |
|
|
|c 27512
|d 110318
|
| 022 |
|
|
|a 0214-4468
|
| 040 |
|
|
|a AR-beUNQ
|e aacr
|
| 099 |
|
|
|a P-ES-SAN1
|
| 210 |
1 |
0 |
|a Sandorama
|
| 245 |
1 |
0 |
|a Sandorama
|c Sandoz Pharma.
|
| 260 |
|
|
|a Barcelona :
|b Sandoz Pharma,
|
| 300 |
|
|
|a v :
|
| 310 |
|
|
|a Trimestral
|
| 362 |
0 |
|
|a No. 1 (1994)-
|
| 500 |
|
|
|a Descripción basada en: No. 1(1994).
|
| 500 |
|
|
|a Datos de contratapa: Sandorama 2a. Serie Monográfica: Oncología.
|
| 650 |
|
7 |
|a Cáncer
|2 Spines
|
| 653 |
|
|
|a Oncología
|
| 653 |
|
|
|a Epidemiología molécular
|
| 710 |
2 |
|
|a Sandoz Pharma.
|
| 866 |
|
0 |
|a 1994 (1)
|
| 929 |
|
|
|d 0
|b Laboratorio de Oncología Molécular
|a DONACION
|j 3957600001
|e 20050526
|
| 942 |
|
|
|c REV
|n 0
|